LexDanaLexDanabeta
Inventor

Zhongli WANG

Inventor
CN

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
Y02PClimate change mitigation technologies in the production or processing of goods20%
PatentTitleYear
12,516,054Pyrazolo[1,5-a]pyridine derivatives, preparation method therefor and use thereof202612,358,898Pyrimidine derivative, method for preparing same and use thereof in medicine202511,827,625Pyrimidine derivative, method for preparing same and use thereof in medicine2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to ZHEJIANG HISUN PHARM CO LTD (2)· patent assignee history
2023–2026Based in CN· patent location history
2026Patents assigned to SHANGHAI DAIDAI INVEST CONSULTING CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ZHEJIANG HISUN PHARM CO LTD22023–2025
SHANGHAI DAIDAI INVEST CONSULTING CO LTD12026
Locations
LocationPatentsSpan
CN32023–2026